Sunday, September 19, 2021

Effects of CBD-Enriched Cannabis sativa Extract on Autism Spectrum Disorder Symptoms

0
Recent observational studies and trials reporting the use of pure CBD or CBD-enriched cannabis extracts for the treatment of syndromes characterized by refractory epilepsy and regressive autism suggest therapeutic potential of cannabinoids for autistic symptoms (47–60). These studies, which include extracts with a CBD/THC ratio of up to 20/1, showed that, even...

How CBD Affects Autism Spectrum Disorder (ASD)

0
…some doctors have been paying attention to the huge and growing amount of anecdotal evidence that CBD, which is contained in cannabis and the hemp plant, is effectively easing the symptoms of autism in children with the condition. Autism is a complicated condition that presents through various symptoms...

Effects of CBD-Enriched Cannabis sativa Extract on Autism Spectrum Disorder Symptoms: An Observational Study of 18 Participants Undergoing Compassionate Use

0
Autism Spectrum Disorders comprise conditions that may affect cognitive development, motor skills, social interaction, communication, and behavior. This set of functional deficits often results in lack of independence for the diagnosed individuals, and severe distress for patients, families, and caregivers. There is a mounting body of evidence indicating the effectiveness of pure...

CBD Oil as a Treatment for Autism

0
Cannabidiol, sometimes called CBD, is a chemical compound found in the cannabis plant. Since it does not include THC, the psychoactive component of cannabis, CBD does not induce a "high." It can, however, help to reduce anxiety and lower stress levels—symptoms that are common among people with autism. Currently, there is some...

The Benefits of Medical Marijuana and CBD Oil for Autism

0
An upcoming study at Children’s Hospital of Philadelphia will be the first of its kind in the United States to examine the benefits of medical marijuana in children with autism spectrum disorder (ASD). The study is in partnership with an Australian biopharmaceutical company called Zelda Therapeutics, who will be funding the study.
- Advertisement -

Must Read